HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Birdwell, R. L. Articles by Jeffrey, S. S. Search for Related Content PubMed PubMed Citation Articles by Birdwell, R. L. Articles by Jeffrey, S. S.

Breast Cancer: Variables Affecting Sentinel Lymph Node Visualization at Preoperative Lymphoscintigraphy¹

¹ From the Departments of Radiology (R.L.B., B.J.B., D.M.I., H.W.S.), Health Research and Policy Division of Biostatistics (B.J.B.), and Surgery (K.L.S., S.S.J.), Stanford University Medical Center, 300 Pasteur Dr, H-1307, Stanford, CA 94305-5105. Received June 20, 2000; revision requested August 29; final revision received January 3, 2001; accepted January 9. Address correspondence to R.L.B. (e-mail: birdwell@stanford.edu).

PURPOSE: To compare patients with visualized sentinel lymph nodes (SLNs) and patients with nonvisualized SLNs, with a focus on variables affecting SLN visualization at preoperative lymphoscintigraphy and on nodal drainage basins as related to tumor location.

MATERIALS AND METHODS: One hundred thirty-six patients who had breast cancer underwent preoperative lymphoscintigraphy before SLN biopsy. Patients with visualized and nonvisualized SLNs were compared for age; tumor site, size, and histologic findings; injection guidance method; diagnostic biopsy type; interval between biopsy and lymphoscintigraphy; intraoperative identification method; and surgical identification rate. Visualized SLN drainage basins were noted.

RESULTS: Ninety-nine patients had visualized and 37 had nonvisualized SLNs, without statistically significant differences in tumor site, size, and histologic findings; injection guidance method; diagnostic biopsy type; and interval between biopsy and lymphoscintigraphy. Ninety-nine (73%) of the 136 SLNs were visualized at lymphoscintigraphy; 30 (81%) of the 37 nonvisualized SLNS were identified at surgery. Of the seven SLNs not identified at surgery, five were mapped with radiocolloid only. Patients with nonvisualized SLNs were older than those with visualized SLNs. Eleven (46%) of 24 tumors with internal mammary drainage were in the outer part of the breast.

CONCLUSION: Patients with and those without visualization differed in age, SLN identification at surgery, and surgical identification method. Nonvisualized status does not preclude axillary metastasis. In older patients with nonvisualized SLNs, blue dye may aid in SLN detection, as compared with isotope-only localization.

Index terms: Breast neoplasms, metastases, 00.30, 00.33 • Breast neoplasms, radionuclide studies, 00.1216 • Breast neoplasms, staging, 00.1216, 00.1261 • Breast neoplasms, surgery, 00.327, 00.329

This article has been cited by other articles:

				I. M. C. van der Ploeg, P. J. Tanis, R. A. V. Olmos, B. B. R. Kroon, E. J. T. Rutgers, and O. E. Nieweg Breast Cancer Patients with Extra-Axillary Sentinel Nodes Only may be Spared Axillary Lymph Node Dissection Ann. Surg. Oncol., November 1, 2008; 15(11): 3239 - 3243. [Abstract] [Full Text] [PDF]

				U. Veronesi, P. Arnone, P. Veronesi, V. Galimberti, A. Luini, N. Rotmensz, E. Botteri, G. B. Ivaldi, M. C. Leonardi, G. Viale, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series Ann. Onc., September 1, 2008; 19(9): 1553 - 1560. [Abstract] [Full Text] [PDF]

				S. P. Povoski, J. O. Olsen, D. C. Young, J. Clarke, W. E. Burak, M. J. Walker, W. E. Carson, L. D. Yee, D. M. Agnese, R. V. Pozderac, et al. Prospective Randomized Clinical Trial Comparing Intradermal, Intraparenchymal, and Subareolar Injection Routes for Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Ann. Surg. Oncol., November 1, 2006; 13(11): 1412 - 1421. [Abstract] [Full Text] [PDF]

				S. P. Harlow Is Preoperative Lymphoscintigraphy Needed for Sentinel Node Procedures in Breast Cancer? Ann. Surg. Oncol., July 1, 2005; 12(7): 515 - 516. [Full Text] [PDF]

				C. Rousseau, J. M. Classe, L. Campion, C. Curtet, F. Dravet, R. Pioud, C. Sagan, B. Bridji, and I. Resche The Impact of Nonvisualization of Sentinel Nodes on Lymphoscintigraphy in Breast Cancer Ann. Surg. Oncol., July 1, 2005; 12(7): 533 - 538. [Abstract] [Full Text] [PDF]

				M Law, K C Cheng, P M Wu, W Y Ho, and L W C Chow Patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a study using a female humanoid phantom and thermoluminescent dosemeters Br. J. Radiol., November 1, 2003; 76(911): 818 - 823. [Abstract] [Full Text] [PDF]

				B. R. Krynyckyi, H. Chun, H. H. Kim, Y. Eskandar, C. K. Kim, and J. Machac Factors Affecting Visualization Rates of Internal Mammary Sentinel Nodes During Lymphoscintigraphy J. Nucl. Med., September 1, 2003; 44(9): 1387 - 1393. [Abstract] [Full Text] [PDF]

				I. Brenot-Rossi, G. Houvenaeghel, J. Jacquemier, V.-J. Bardou, M. Martino, N. Hassan-Sebbag, and J. Pasquier Nonvisualization of Axillary Sentinel Node During Lymphoscintigraphy: Is There a Pathologic Significance in Breast Cancer? J. Nucl. Med., August 1, 2003; 44(8): 1232 - 1237. [Abstract] [Full Text] [PDF]